Gilead Sciences Aktie

60,20EUR
-0,53EUR
-0,87%
68,51USD
+0,70USD
+1,03%

WKN: 885823 / ISIN: US3755581036 / Symbol: GILD

  Kaufen  
Verkaufen
oder
mehr Daten anzeigen
Werbung

Gilead Sciences Aktie Analyse

15.06.20 Gilead Sciences kaufen DZ BANK
15.03.19 Gilead Sciences Outperform BMO Capital Markets
03.01.19 Gilead Sciences Outperform Oppenheimer & Co. Inc.
26.10.18 Gilead Sciences overweight Barclays Capital
01.10.18 Gilead Sciences Overweight Cantor Fitzgerald
26.07.18 Gilead Sciences Neutral Robert W. Baird & Co. Incorporated
02.05.18 Gilead Sciences Buy Maxim Group
06.03.18 Gilead Sciences overweight Barclays Capital
Werbung
12.02.18 Gilead Sciences Buy Mizuho
30.11.17 Gilead Sciences Buy Maxim Group
08.11.17 Gilead Sciences Buy Mizuho
11.10.17 Gilead Sciences overweight Barclays Capital
05.10.17 Gilead Sciences Perform Oppenheimer & Co. Inc.
15.09.17 Gilead Sciences Outperform RBC Capital Markets
23.06.17 Gilead Sciences Buy Deutsche Bank AG
09.03.17 Gilead Sciences Neutral UBS AG
14.11.16 Gilead Sciences Buy Stifel, Nicolaus & Co., Inc.
08.11.16 Gilead Sciences Buy Mizuho
02.11.16 Gilead Sciences Outperform RBC Capital Markets
03.10.16 Gilead Sciences Outperform RBC Capital Markets
01.06.16 Gilead Sciences Buy Gabelli & Co
29.04.16 Gilead Sciences Buy UBS AG
29.04.16 Gilead Sciences Hold Maxim Group
08.04.16 Gilead Sciences Market Perform BMO Capital Markets
28.10.15 Gilead Sciences Buy Maxim Group
20.10.15 Gilead Sciences Outperform Oppenheimer & Co. Inc.
29.07.15 Gilead Sciences overweight Barclays Capital
29.07.15 Gilead Sciences Buy Deutsche Bank AG
29.07.15 Gilead Sciences Outperform Oppenheimer & Co. Inc.
29.07.15 Gilead Sciences Buy Needham & Company, LLC
29.07.15 Gilead Sciences Buy Maxim Group
29.07.15 Gilead Sciences Outperform RBC Capital Markets
23.06.15 Gilead Sciences Buy Argus Research Company
01.05.15 Gilead Sciences Outperform RBC Capital Markets
04.02.15 Gilead Sciences Outperform RBC Capital Markets
23.12.14 Gilead Sciences Buy Deutsche Bank AG
09.12.14 Gilead Sciences Buy Argus Research Company
29.10.14 Gilead Sciences Outperform RBC Capital Markets
13.10.14 Gilead Sciences Outperform FBR Capital
25.09.14 Gilead Sciences Buy Needham & Company, LLC
11.01.13 Gilead Sciences kaufen boerse.de-Aktienbrief
10.01.13 Gilead Sciences kaufen Aktienservice Research
18.12.12 Gilead Sciences buy UBS AG
14.12.12 Gilead Sciences neutral Goldman Sachs Group Inc.
03.12.12 Gilead Sciences overweight Piper Jaffray & Co.
15.11.12 Gilead Sciences outperform RBC Capital Markets
14.11.12 Gilead Sciences buy Deutsche Bank Securities
13.11.12 Gilead Sciences buy Stifel, Nicolaus & Co., Inc.
13.11.12 Gilead Sciences neutral Credit Suisse Group
12.11.12 Gilead Sciences buy UBS AG
Seite: 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10

Analysensuche

GO
Werbung

Aktuelle News zu

finanzen.net zero
finanzen.net zero

Oskar

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.
Zur klassischen Ansicht wechseln